Phosphodiesterase type 5 inhibitors for the treatment of sexual dysfunction in males with major depressive disorder: A systematic review and meta-analysis

被引：0
|
作者：
Sakuma, Kenji [1 ]
Kishi, Taro [1 ]
Sanji, Shohei [2 ]
Nomura, Ikuo [3 ]
Hatano, Masakazu [1 ,4 ]
Okuya, Makoto [5 ]
Iwata, Nakao [1 ]
机构：
[1] Fujita Hlth Univ, Dept Psychiat, Sch Med, Toyoake, Japan
[2] Fujita Hlth Univ, Dept Med, Toyoake, Japan
[3] Okehazama Hosp, Dept Psychiat, Toyoake, Japan
[4] Fujita Hlth Univ, Dept Clin Pharm, Sch Med, Toyoake, Japan
[5] Toyota Mem Hosp, Dept Psychiat, Toyota, Japan
来源：
PSYCHIATRY AND CLINICAL NEUROSCIENCES | 2023年 / 77卷 / 05期
关键词：
NETWORK;
D O I：
10.1111/pcn.13537
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction
    Gao, Liang
    Yang, Lu
    Qian, Shengqiang
    Li, Tao
    Han, Ping
    Yuan, Jiuhong
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2016, 133 (02) : 139 - 145
  • [2] Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis
    Ahmad, Abdullah
    Awan, Abdul Rafeh
    Nadeem, Natasha
    Javed, Aamir Shahid
    Farooqi, Mobeen
    Daniyal, Muhammed
    Mumtaz, Hassan
    FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [3] Phosphodiesterase Type 5 Inhibitors for Premature Ejaculation: A Systematic Review and Meta-analysis
    James, Marrissa Martyn-St
    Cooper, Katy
    Ren, Shijie
    Kaltenthaler, Eva
    Dickinson, Kath
    Cantrell, Anna
    Wylie, Kevan
    Frodsham, Leila
    Hood, Catherine
    EUROPEAN UROLOGY FOCUS, 2017, 3 (01): : 119 - 129
  • [4] Systematic Review and Meta-Analysis of Vortioxetine for the Treatment of Major Depressive Disorder in Adults
    Zhang, Xinyan
    Cai, Yuchun
    Hu, Xiaowen
    Lu, Christine Y.
    Nie, Xiaoyan
    Shi, Luwen
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [5] Combination of Antidepressants in the Treatment of Major Depressive Disorder A Systematic Review and Meta-Analysis
    Rocha, Fabio Lopes
    Fuzikawa, Cintia
    Riera, Rachel
    Hara, Claudia
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (02) : 278 - 281
  • [6] Phosphodiesterase 5 inhibitors for the treatment of heart failure: a systematic review and meta-analysis
    Monzon-Herrera, Ramiro
    Listorti, Federico
    Vensentini, Natalia
    Mariani, Javier
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2024, 94 (03): : 309 - 323
  • [7] Efficacy of phosphodiesterase type 5 inhibitors for the treatment of distal ureteral calculi: A systematic review and meta-analysis
    Montes Cardona, Carlos Eduardo
    Andres Garcia-Perdomo, Herney
    INVESTIGATIVE AND CLINICAL UROLOGY, 2017, 58 (02) : 82 - +
  • [8] Relation of phosphodiesterase type 5 inhibitors and malignant melanoma: a meta-analysis and systematic review
    Wang, Jie
    Shen, Yigen
    Wang, Jiaoni
    Xue, Yangjing
    Liao, Lianming
    Thapa, Saroj
    Ji, Kangting
    ONCOTARGET, 2017, 8 (28) : 46461 - 46467
  • [9] The efficacy of vortioxetine in the acute treatment of major depressive disorder: A systematic review and meta-analysis
    Berardelli, Isabella
    Rogante, Elena
    Formica, Federico
    Iannazzo, Riccardo
    Mammoliti, Attilio Valerio
    Riccioni, Raffaele
    Veizi, Skender
    Mcintyre, Roger S.
    Pompili, Maurizio
    JOURNAL OF PSYCHOPHARMACOLOGY, 2025, 39 (02) : 92 - 105
  • [10] Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis
    Yuan, JinQiu
    Zhang, RenJie
    Yang, ZuYao
    Lee, Jack
    Liu, YaLi
    Tian, JinHui
    Qin, XiWen
    Ren, ZhengJia
    Ding, Hong
    Chen, Qing
    Mao, Chen
    Tang, JinLing
    EUROPEAN UROLOGY, 2013, 63 (05) : 902 - 912
12345